Cytokinetics Sets PDUFA Target Action Date for Aficamten on
Jan 13, 2025 · Cytokinetics, Inc. announced that the target action date for aficamten's approval is set for September 26, 2025, as the company prepares for its commercial launch in the U.S.
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension